OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
Saikat Dewanjee, V. Jayalakshmi, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1340-1340
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 721

Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 111

The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Gilbert Ogunmokun, Saikat Dewanjee, Pratik Chakraborty, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2790-2790
Open Access | Times Cited: 52

HDAC11, an emerging therapeutic target for metabolic disorders
Huizhen Chen, Chunguang Xie, Qiu Chen, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33

Targeting histone deacetylases: Emerging applications beyond cancer
Yasir S. Raouf
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104094-104094
Closed Access | Times Cited: 7

The Complex Interplay between Imbalanced Mitochondrial Dynamics and Metabolic Disorders in Type 2 Diabetes
Tin Van Huynh, Lekha Rethi, Lekshmi Rethi, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1223-1223
Open Access | Times Cited: 15

Expanding Role of Epigenetics in Human Health and Disease
Swarup K. Chakrabarti, Dhrubajyoti Chattopadhyay
Exploratory Research and Hypothesis in Medicine (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 5

Post-Translational Modifications and Diabetes
Chiranjeev Sharma, Abu Hamza, Emily Boyle, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 310-310
Open Access | Times Cited: 5

Targeting Nrf2 by bioactive peptides alleviate inflammation: expanding the role of gut microbiota and metabolites
Zhongxing Chu, Lingfeng Zhu, Yaping Zhou, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-20
Closed Access | Times Cited: 5

Anticancer potential of ferrocene-containing derivatives: Current and future prospective
Vijesh Tomar, Parveen Kumar, Deepak Sharma, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139589-139589
Closed Access | Times Cited: 5

Food Phytochemicals as Epigenetic Modulators in Diabetes: A Systematic Review
Fahrul Nurkolis, Nurpudji Astuti Taslim, Rony Abdi Syahputra, et al.
Journal of Agriculture and Food Research (2025), pp. 101873-101873
Open Access

Understanding the prospective of gene therapy for the treatment of breast cancer
Ritika Ritika, Sweta Rani, Rishabha Malviya, et al.
Revista de Senología y Patología Mamaria (2025) Vol. 38, Iss. 4, pp. 100683-100683
Closed Access

Epigenetic Alterations in Podocytes in Diabetic Nephropathy
Erina Sugita, Kaori Hayashi, Akihito Hishikawa, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23

Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity
Bastian Ramms, Dennis P. Pollow, Han Zhu, et al.
Diabetes (2022) Vol. 71, Iss. 12, pp. 2513-2529
Open Access | Times Cited: 13

Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management
Lisha Ye, Wenfeng Li, Xiaoyan Tang, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 14, pp. 2298-2313
Closed Access | Times Cited: 2

Histone deacetylases and inhibitors in diabetes mellitus and its complications
Wang Li, Yuning Bai, Zhengmin Cao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117010-117010
Open Access | Times Cited: 2

Histone deacetylase inhibitors as antidiabetic agents: Advances and opportunities
Manisha Sonthalia, Bhramar Sinha Roy, Divya Chandrawanshi, et al.
European Journal of Pharmacology (2022) Vol. 935, pp. 175328-175328
Closed Access | Times Cited: 12

Role of Histone Deacetylase Inhibitor in Diabetic Painful Neuropathy
Vikram Thakur, Mayra A. Gonzalez, Maria Parada, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 4, pp. 2283-2296
Closed Access | Times Cited: 6

Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies
Marcella Conning-Rowland, Richard M. Cubbon
Diabetes and Vascular Disease Research (2023) Vol. 20, Iss. 6
Open Access | Times Cited: 6

Histone acetyltransferase inhibition reverses opacity in rat galactose-induced cataract
Masaya Nagaya, Risa Yamaoka, Fumito Kanada, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0273868-e0273868
Open Access | Times Cited: 10

Butyrate and Class I Histone Deacetylase Inhibitors Promote Differentiation of Neonatal Porcine Islet Cells into Beta Cells
Yichen Zhang, Yutian Lei, Mohsen Honarpisheh, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3249-3249
Open Access | Times Cited: 14

The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease
Gilbert Ogunmokun, Saikat Dewanjee, Pratik Chakraborty, et al.
(2021)
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top